Yoritaka Asako

Affiliation and department：

Research field (1)： Basic brain sciences

Research keywords (5)： exercise , 臨床神経学 , 神経感染症 , Clinical trial , Parkinson disease

Research theme for competitive and other funds (7)：

2022 - 2026 Visual cognition in Parkinson's disease and research of early surrogate marker
2022 - 2026 パーキンソン病患者の運動療法による神経保護効果因子の検証
2015 - 2018 [研究代表者]水素水飲水によるパーキンソン病に対する多施設共同無作為化2重盲検試験
2014 - 2017 Clinical Analysis of Neurodegenerative Dementia Using Cerebrospinal Fluid Biomarkers
2011 - 2015 Randomized, double-blind, placebo-controlled trial of reduced form of coenzyme Q10 of Parkinson's disease

Show all

Papers (75)：

Noriko Nishikawa, Taku Hatano, Kenya Nishioka, Shin-Ichi Ueno, Shinji Saiki, Ryota Nakamura, Asako Yoritaka, Takashi Ogawa, Yasushi Shimo, Wataru Sako, et al. Safinamide as adjunctive therapy to levodopa monotherapy for patients with Parkinson's disease with wearing-off: The Japanese observational J-SILVER study. Journal of the neurological sciences. 2024. 461. 123051-123051
Taku Hatano, Renpei Sengoku, Hiroshi Nagayama, Naotake Yanagisawa, Asako Yoritaka, Keisuke Suzuki, Noriko Nishikawa, Yohei Mukai, Kyoichi Nomura, Norihito Yoshida, et al. Impact of Istradefylline on Levodopa Dose Escalation in Parkinson's Disease: ISTRA ADJUST PD Study, a Multicenter, Open-Label, Randomized, Parallel-Group Controlled Study. Neurology and therapy. 2024
Asako Yoritaka, Tetsuo Hayashi, Keiko Fusegi, Sachiko Nakayama, Jun Haneda, Nobutaka Hattori. Hypoperfusion in Supramarginal and Orbital Gyrus, Position Discrimination Test, and Microsaccades as a Predictor of Pisa Syndrome in Parkinson's Disease. Parkinson's disease. 2024. 2024. 5550362-5550362
西川典子, 波田野琢, 上野真一, 斉木臣二, 西岡健弥, 中村亮太, 小川崇, 頼高朝子, 下泰司, 佐光亘, et al. Wearing off現象が認められるパーキンソン病患者を対象としたレボドパ単剤治療へのサフィナミド併用療法に関する観察研究(J-SILVER study). 日本神経精神薬理学会年会プログラム・抄録集. 2023. 53回. 159-159
Taku Hatano, Osamu Kano, Renpei Sengoku, Asako Yoritaka, Keisuke Suzuki, Noriko Nishikawa, Yohei Mukai, Kyoichi Nomura, Norihito Yoshida, Morinobu Seki, et al. Evaluating the impact of adjunctive istradefylline on the cumulative dose of levodopa-containing medications in Parkinson's disease: study protocol for the ISTRA ADJUST PD randomized, controlled study. BMC neurology. 2022. 22. 1. 71-71

ｍore...

MISC (49)：

林徹生, 林徹生, 頼高朝子, 布施木景子, 服部信孝. アルツハイマー病患者に対する運転映像のアイトラッキングによる解析. Dementia Japan. 2021. 35. 4
頼高朝子, 下泰司, 波田野琢, 服部信孝. パーキンソン病の運動症状、非運動症状の前方視的観察頻度とリスク. パーキンソン病・運動障害疾患コングレスプログラム・抄録集. 2018. 12回. 76-76
頼高朝子, 大塚千久美, 前田哲也, 平山正昭, 渡辺宏久, 阿部隆志, 斉木英資, 大山彦光, 下泰司, 波多野琢, et al. Parkinson病に対する水素水の多施設共同二重盲検並行群間試験. パーキンソン病・運動障害疾患コングレスプログラム・抄録集. 2017. 11回. 90-90
Yoritaka, A., Abe, T., Ohtsuka, C., Maeda, T., Hirayama, M., Watanabe, H., Saiki, H., Oyama, G., Fukae, J., Shimo, Y., et al. Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: Protocol and baseline characteristics. [BMC Neurol. 16, (2016), (66)] DOI: 10.1186/s12883-016-0589-0. BMC Neurology. 2017. 17. 1. 35-35
A. Yoritaka, H. Mori, N. Hattori. Differences between responders and non-responders of Istradefylline for the wearing off in Parkinson's disease. MOVEMENT DISORDERS. 2016. 31. S245-S245

ｍore...

Professional career (1)：

医学博士 (順天堂大学)

Awards (1)：

2018/07 - 第12回パーキンソン病・運動障害コングレス優秀演題ポスター賞(臨床)

Association Membership(s) (7)：

THE JAPAN STROKE SOCIETY , 日本頭痛学会 , 日本神経感染症学会 , Movement Disorder Society , Movement Disorder Society of Japan , THE JAPANESE SOCIETY OF INTERNAL MEDICINE , JAPANESE SOCIETY OF NEUROLOGY

※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page